Discover the impact of CVE-2023-38003, a high-severity IBM Db2 vulnerability allowing unauthorized routine execution by privileged users. Learn mitigation steps.
A detailed overview of the IBM Db2 command execution vulnerability.
Understanding CVE-2023-38003
This section provides insights into the IBM Db2 vulnerability discovered in 2023.
What is CVE-2023-38003?
The CVE-2023-38003 vulnerability affects IBM Db2 for Linux, UNIX, and Windows versions 10.5, 11.1, and 11.5. It allows a user with DATAACCESS privileges to execute routines they should not have access to.
The Impact of CVE-2023-38003
The vulnerability poses a high risk with a CVSS v3.1 base score of 7.2, categorized as 'HIGH' severity. It could lead to unauthorized execution of routines by privileged users, compromising data confidentiality, integrity, and availability.
Technical Details of CVE-2023-38003
Explore the specific technical aspects of the CVE-2023-38003 vulnerability.
Vulnerability Description
IBM Db2 for Linux, UNIX, and Windows versions 10.5, 11.1, and 11.5 allows users with DATAACCESS privileges to execute routines beyond their access rights, potentially leading to unauthorized data manipulation.
Affected Systems and Versions
The vulnerability impacts IBM Db2 for Linux, UNIX, and Windows versions 10.5, 11.1, and 11.5.
Exploitation Mechanism
The vulnerability can be exploited by users with DATAACCESS privileges to execute routines they are not authorized to access, compromising system security.
Mitigation and Prevention
Learn how to mitigate and prevent the IBM Db2 command execution vulnerability.
Immediate Steps to Take
IBM recommends restricting user privileges, applying security patches, and monitoring system activity to prevent unauthorized routine executions.
Long-Term Security Practices
Enhance security by regularly updating IBM Db2 software, educating users on safe practices, and implementing access control measures.
Patching and Updates
Stay vigilant for security updates from IBM and promptly apply patches to address the vulnerability.